1. Home
  2. TECX vs FAX Comparison

TECX vs FAX Comparison

Compare TECX & FAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • FAX
  • Stock Information
  • Founded
  • TECX 2019
  • FAX 1986
  • Country
  • TECX United States
  • FAX United States
  • Employees
  • TECX N/A
  • FAX N/A
  • Industry
  • TECX
  • FAX Investment Managers
  • Sector
  • TECX
  • FAX Finance
  • Exchange
  • TECX Nasdaq
  • FAX Nasdaq
  • Market Cap
  • TECX 387.1M
  • FAX 658.9M
  • IPO Year
  • TECX 2018
  • FAX N/A
  • Fundamental
  • Price
  • TECX $15.06
  • FAX $16.72
  • Analyst Decision
  • TECX Buy
  • FAX
  • Analyst Count
  • TECX 6
  • FAX 0
  • Target Price
  • TECX $79.17
  • FAX N/A
  • AVG Volume (30 Days)
  • TECX 502.6K
  • FAX 833.6K
  • Earning Date
  • TECX 11-06-2025
  • FAX 01-01-0001
  • Dividend Yield
  • TECX N/A
  • FAX 12.09%
  • EPS Growth
  • TECX N/A
  • FAX N/A
  • EPS
  • TECX N/A
  • FAX N/A
  • Revenue
  • TECX N/A
  • FAX N/A
  • Revenue This Year
  • TECX N/A
  • FAX N/A
  • Revenue Next Year
  • TECX N/A
  • FAX N/A
  • P/E Ratio
  • TECX N/A
  • FAX N/A
  • Revenue Growth
  • TECX N/A
  • FAX N/A
  • 52 Week Low
  • TECX $13.70
  • FAX $2.33
  • 52 Week High
  • TECX $61.07
  • FAX $2.84
  • Technical
  • Relative Strength Index (RSI)
  • TECX 31.98
  • FAX 63.63
  • Support Level
  • TECX $15.92
  • FAX $16.43
  • Resistance Level
  • TECX $18.61
  • FAX $16.84
  • Average True Range (ATR)
  • TECX 1.60
  • FAX 0.16
  • MACD
  • TECX -0.46
  • FAX 0.03
  • Stochastic Oscillator
  • TECX 0.49
  • FAX 74.65

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About FAX abrdn Asia-Pacific Income Fund Inc.

Aberdeen Asia-pacific Income Fund Inc is a United States-based closed-end, non-diversified management investment company. Its principal investment objective is to seek current income along with capital appreciation. The fund invests in Asian debt securities, Australian debt securities, European debt securities and others.

Share on Social Networks: